Belgian startup Indigo Diabetes scores €38 million to develop its under the skin CGM sensor

The company is looking to test the product in the U.S. and Europe, with the goal of gaining market approval for both regions by 2023.  
Source: mobihealthnews - Category: Information Technology Source Type: news